Your browser doesn't support javascript.
Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.
Clayton-Chubb, Daniel; Schneider, Daniel; Freeman, Elliot; Kemp, William; Roberts, Stuart K.
  • Clayton-Chubb D; Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia. Electronic address: d.clayton-chubb@alfred.org.au.
  • Schneider D; Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia.
  • Freeman E; Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia.
  • Kemp W; Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia; Central Clinical School, Department of Medicine, Monash University, Melbourne, Victoria, Australia.
  • Roberts SK; Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia; Central Clinical School, Department of Medicine, Monash University, Melbourne, Victoria, Australia.
J Hepatol ; 75(5): 1249-1250, 2021 11.
Article in English | MEDLINE | ID: covidwho-1461334

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Hepatitis, Autoimmune / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Hepatol Journal subject: Gastroenterology Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Hepatitis, Autoimmune / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Hepatol Journal subject: Gastroenterology Year: 2021 Document Type: Article